---
title: "Arch Therapeutics, Inc. (ARTH.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ARTH.US/norm.md"
symbol: "ARTH.US"
name: "Arch Therapeutics, Inc."
parent: "https://longbridge.com/en/quote/ARTH.US.md"
datetime: "2026-03-15T16:02:53.653Z"
locales:
  - [en](https://longbridge.com/en/quote/ARTH.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ARTH.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ARTH.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/ARTH.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ARTH.US/norm.md)


# Arch Therapeutics, Inc. (ARTH.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
| --- | --- | --- | --- | --- | --- |
| EPS | -1.44 | -0.3267 | -0.5697 | -0.2891 | -1.42 |
| ROE | 217.93% | 57.46% | 125.58% | 126.64% | 101.28% |
| Revenue | 30913.00 | 31866.00 | 45867.00 | 39517.00 | 13293.00 |
| Net income | -6.38M | -1.47M | -2.68M | -2.46M | -1.82M |

## Balance Sheet (USD)

| Indicator | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
| --- | --- | --- | --- | --- | --- |
| A&L | 1.40M | 1.54M | 1.82M | 1.96M | 1.56M |
| Leverage | -0.1113 | -0.1416 | -0.1903 | -0.2608 | -0.1952 |
| BVPS | -2.83 | -2.45 | -2.02 | -1.60 | -6.24 |
| Turnover | 0.1000 | 0.0833 | 0.0652 | 0.0332 | 0.0241 |

## Cash Flow Statement (USD)

| Indicator | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -911641.00 | -700159.00 | -862605.00 | -1.23M | -897549.00 |
| Investing CF | - | - | - | -4521.00 | - |
| Financing CF | 915245.00 | 520735.00 | 845735.00 | 1.37M | 954596.00 |
| Free CF | -316737.00 | -305268.00 | -369822.00 | -706862.00 | -369055.00 |